Glatiramer Acetate Depot for treating relapsing forms of multiple sclerosis in adults aged 18 to 55 years

Glatiramer Acetate (GA) Depot is currently in development for the treatment of relapsing forms of multiple sclerosis (MS). MS is a neurological autoimmune condition that causes problems with vision, arm or leg movement, sensation and/or balance. Relapsing MS (RMS) is the most common type of MS and those living with it will have episodes of new or worsening symptoms i.e., relapses which are generally followed by periods of partial or complete recovery (remissions). There is no cure for MS, but treatments can be used to manage symptoms; to reduce the number of relapses, delay disease progression or disability, and limit new disease activity. Specifically, for RMS, disease modifying therapies are used. Patients currently administer medication daily; additional treatments are required to reduce the number of treatments required whilst also reducing relapses.